Results 221 to 230 of about 7,212 (251)

DMPA and HIV: why we need a trial

Contraception, 2014
Recent articles by Ralph et al. [1,2] and Gollub and Stein [3], as well as an accompanying commentary by Jones [4] in the current issue of Contraception, have challenged the concept of conducting a randomized trial to determine whether injectable depot medroxyprogesterone acetate (DMPA) increases the risk of HIV acquisition.
openaire   +2 more sources

DMPA use above the age of 35 in Thai women

Contraception, 2000
A prospective study of depot-medroxyprogesterone acetate (DMPA) use in women aged above 35 years was conducted in Bangkok, Thailand. The objectives of the study were to evaluate efficacy, continuation rate, and side effects of DMPA use in these women. A total of 60 women were enrolled in a one-year clinical trial. Their mean age was 38 years.
S, Taneepanichskul, D, Reinprayoon, S, Phaosavadi   +2 more
openaire   +2 more sources

Safety of DMPA

The Lancet, 1991
A, Szareswki, J, Guillebaud
openaire   +2 more sources

Use of DMPA by Adolescents

Journal of Pediatric and Adolescent Gynecology, 2005
Melanie A, Gold, S Paige, Hertweck, Eduardo, Lara-Torre   +2 more
openaire   +2 more sources

Bone mineral density and DMPA.

The Journal of reproductive medicine, 2003
The relationship between depot medroxyprogesterone acetate (DMPA) and changes in bone mineral density remains controversial despite a substantial number of studies evaluating this potential association and its clinical relevance. While the majority of prospective studies suggest that DMPA produces a modest decline in bone density, several have failed ...
openaire   +1 more source

PFPP re-introduces DMPA.

IMCH newsletter, 1995
The Philippine Family Planning Program formally re-introduced depomedroxyprogesterone acetate (DMPA) or DepoProvera as a program method last March 22, 1994. DMPA will be added to the choices available to couples who desire to practice responsible parenthood.
openaire   +1 more source

Recognizing DMPA as a Contraceptive

The American Journal of Nursing, 1984
openaire   +2 more sources

Current concepts regarding use of DMPA.

The Journal of reproductive medicine, 2003
Since its introduction, depot medroxyprogesterone acetate (DMPA) has proven to be among the most effective methods of reversible contraception. The unique set of characteristics that distinguish this method from other contraceptive options may render it the most suitable method of pregnancy prevention for many women.
openaire   +1 more source

DMPA-IM, DMPA-SC: Side Effect Differences Few

Pediatric News, 2010
openaire   +1 more source

DMPA, zalcitabine, and the FDA

The Lancet, 1992
openaire   +1 more source